🇺🇸 FDA
Pipeline program

Dimethyl fumarate

haojunwei2

Phase 2 small_molecule terminated

Quick answer

Dimethyl fumarate for Intracerebral Hemorrhage is a Phase 2 program (small_molecule) at Xuanwu Hospital, Beijing with 1 ClinicalTrials.gov record(s).

Program details

Company
Xuanwu Hospital, Beijing
Indication
Intracerebral Hemorrhage
Phase
Phase 2
Modality
small_molecule
Status
terminated

Clinical trials